Introduction {#sec1-1}
============

Lesion by toxic analogs of neurotransmitters is useful because of lack of lesion selectivity in the specific cell populations. This fact raises much serious problem whenever one attempts to ascribe the effects of specific cell population removal on the neurophysiology and the neuronal transmission. Colchicine is a plant alkaloid,\[[@ref1]\] which is known as a potent inhibitor of physiological processes. The alkaloid specifically binds to the receptor site on the tubulin\[[@ref2]\] and blocks mitosis.\[[@ref3]\] Goldschmidt and Steward\[[@ref4]\] have previously demonstrated the colchicine as a substance, which preferentially destructs the granule cells in the dentate gyrus. However, the toxic effect of colchicine on other cellular processes rather tubulin subunits has been specified later.\[[@ref5]\] After Correia and Lobert,\[[@ref5]\] damage of pyramidal cells in the cortical area 1 (CA1) of the hippocampus was shown by this laboratory.\[[@ref6]\] This neurointoxication is surprisingly important because neuronal functions depend on an intact cytoskeleton. The cytoskeletal alterations are associated with neurological disorders,\[[@ref7]\] which is notably common in cases of neurodegenerative pathology.\[[@ref8]\] This lesion also may refer to the learning and spatial memory impairment,\[[@ref9]\] because the hippocampal sub-regions are referenced as those that function in spatial and working memory processes.\[[@ref10]\] We aim to show a selective neurotoxic effect of colchicine in the small pyramidal cell populations in CA1 area of rat hippocampus through evaluation of novelty seeking behavior

Materials and Methods {#sec1-2}
=====================

 {#sec2-1}

### Animals {#sec3-1}

The animals used were male Wistar rats (Pasteur Institute of Iran, Tehran, Iran) weighing between 250 g and 350 g. They were housed two per cage in a controlled colony room (temperature 21°C ± 3°C). They were maintained under a 12:12 h light-dark cycle with water and food provided *ad libitum*. 6 animals were used in each experiment and all experiments were approved by the local ethics committee.

### Drugs {#sec3-2}

The drug colchicine (Merck Co., Germany) used in the present study was prepared in sterile 0.9% NaCl solution. A mixture level of 5:2 of ketamine (100 mg/kg) and xylazine (20 mg/kg) purchased from Veterinary organization of Iran were intraperitoneally (i.p.) injected to anesthetize the experimental animals. Vehicle injections were of the appropriate volume of 0.9% physiological saline.

### Surgery and colchicine injection {#sec3-3}

The animals were anesthetized and placed in a stereotaxic apparatus, with the incisor bar set at approximately, 3.3 mm below horizontal zero to achieve a flat skull position. An incision was made to expose the rat skull. Two holes were drilled in the skull at stereotaxic coordinates: AP-3.8 mm posterior to bregma, and L ± 1.8 to ± 2.2 mm according to the atlas of Paxinos and Watson.\[[@ref11]\] Two guide cannulae (21-gauge) were inserted into the holes. For animals receiving bilateral injections of colchicine into the CA1 of the hippocampus, the guide cannula were lowered 2 mm below bregma through the holes drilled at the above-mentioned coordinates.

The colchicine (1, 5, 25, and 75 μg/rat) was administered intra-CA1 of the hippocampus while the cannulated rats were still settled down by the stereotaxic apparatus. The guide cannula was anchored with a jeweler\'s screw, and the incision was closed with the dental cement. After that, the injection cannula that extended 1 mm beyond the guide cannula was inserted into the guide cannula through, which the alkaloid (1-75 μg/rat) was gently injected into the site. The injection cannula then was left in the place for another 60 s to facilitate the diffusion of the drug. One week after the recovery the rats passed the novelty seeking task by the place conditioning procedure.

### Histological verification {#sec3-4}

After completion of experiments, the animals were decapitated on the usage of overdose of chloroform. The brains were removed and fixed in a 10% formalin solution for 48 h before sectioning. Sections were taken through the brain areas of cannula placements, and the cannula placements were verified using the atlas of Paxinos and Watson.\[[@ref11]\] Data from rats with injection sites located outside the hippocampal CA1 area was excluded of the analysis.

### Cresyl violet stain {#sec3-5}

Thin (4-5 μm) brain sections provided by paraffin blocks were cleared of paraffin by xylol and xylol-alcohol and placed in 95%, 75%, and 50% ethanol and distilled water for 30 s each and administered with cresyl violet solution (Merck Co., Germany) for 2 min. Subsequently, the sections were placed in 0.1% acetic acid (about 10 s) and in 50%, 75%, and 95% ethanol for 30 s each, cleared in xylene and mounted with entallen glue (Merck Co., Germany).

### Statistical analysis {#sec3-6}

The data were analyzed with One-way analysis of variance (ANOVA) followed by the Tukey-Kramer multiple comparison tests. *P* values \< 0.05 were considered as significant.

### Place conditioning apparatus {#sec3-7}

A two compartment conditioned place preference apparatus (30 cm × 60 cm × 30 cm) was used in the experiment. Place conditioning was conducted using an unbiased procedure, with the design and the apparatus previously been described.\[[@ref12]\]

### Novelty seeking task by the place conditioning paradigm {#sec3-8}

The experiment consisted of three following phases:

### Familiarizing {#sec3-9}

On day 1 (before confining) animals received one habituation session. They were placed in the middle-line of the apparatus to freely move into the entire apparatus for 10 min. In this phase, the removable wall was raised 12 cm above the floor. The time spent by rats in each compartment was recorded by an Ethovision system (Auto iris Video Camera LVC-DV323ec, LG Electronics, South Korea) located 120 cm above the apparatus. The recorded behavior by the system was then analyzed by an observer had no knowledge of the treatments. None of the groups displayed a significant preference for one of the compartments, confirming that this procedure is unbiased.

### Confining {#sec3-10}

This phase was started 1 day after the familiarization. It consisted of 6-part pairings; the animals were simply confined for 40 min in one part of the box twice a day with a 6-h interval. This phase was carried out during the light phase of a 12-h light/dark cycle (e.g., at 09.00 a.m. and at 15.00 p.m.). This protocol was as performed in the control (saline treated) group as carried out for the experimental groups (colchicine 1-75 μG/rat treated intra-CA1).

### Testing {#sec3-11}

Test session was carried out on day 5, 1 day after the last confining session. Each animal was tested only once. For testing, the removable wall was raised 12 cm above the floor and each animal was allowed free access to both compartments of the apparatus for 10 min. The time spent (s) in the compartments on day of testing were subtracted between those obtained for the familiarization and the testing phases and the result was expressed as mean ± S.E.M. Count of behavioral signs as the change in number of the sign/10 min performed in the apparatus was also counted.

Results {#sec1-3}
=======

 {#sec2-2}

### Cell damage induced by colchicine in the area of CA1 of Wistar rats {#sec3-12}

The colchicine (1-75 μg/rat) was effective in inducing of lesion in the layer CA1 \[[Figure 1](#F1){ref-type="fig"}\].

![The histological verifications of colchicine lesion effect (1-75 μg/rat, intra-CA1) in Wistar rats. The injection of colchicine was carried out only once. After receiving the drug each animal was allowed to recover. Then the animal passed the behavioral experiments. The alkaloid damaging effect in the experimental animals is shown in the figure \[[Figure 1b](#F1){ref-type="fig"}\] in contrast to the control \[[Figure 1a](#F1){ref-type="fig"}\]](IJPharm-45-274-g001){#F1}

### Effect of injection of colchicine intra-CA1 on score of staying {#sec3-13}

Bilateral injection of colchicine (1-75 μg/rat, intra-CA1), a plant derived alkaloid, before (1 week) starting the process of novelty seeking, resulted in a significant difference in the score of staying in the novel part in the rats compared to the control group (F~4,24~= 6.584, *P* \< 0.01) \[[Figure 2](#F2){ref-type="fig"}\].

![Response to colchicine or saline (control), intra-CA1, in the novelty behavior using the place conditioning task. Each animal, after being recovered, passed the task detailed in the Materials and Methods. The animals were tested in last day to evaluate a simple type of learning. Data are expressed as the score of change in seeking for the novel place and expressed as mean ± S.E.M. A difference between drug-administered groups versus the vehicle was observed. *Post hoc* analysis by Tukey showed the differences (\**P*\< 0.05) to the control](IJPharm-45-274-g002){#F2}

### Effect of injection of colchicine intra-CA1 on behavioral signs {#sec3-14}

[Figure 3](#F3){ref-type="fig"} shows the effect of colchicine injection (1-75 μg/rat, intra-CA1) on behavioral signs in Wistar rats. Administration of neurotoxin showed significant effect on compartment entering (F~4,24~= 3.911; *P* \< 0.05). However, no significant effect on sniffing, rearing or grooming was recorded (*P* \> 0.05).

![The behavioral signs in male Wistar rats that received colchicine or saline (control) intra-CA1. The colchicine (1-75 μg/rat) or saline (1 μl/rat) was given 1 week before of starting of the novelty paradigm. The animals then passed the task as detailed in M and M. Data are expressed as change in count of behavioral signs per 10 min ± SEM. *Post hoc* analysis by Tukey showed the difference (\**P*\<0.05) to the control](IJPharm-45-274-g003){#F3}

Discussion {#sec1-4}
==========

This research was designed to survey the effect of a potent plant neurotoxin, colchicine, on small pyramidal cells in the hippocampal CA1 and the seeking behavior in the conditioning task as well. We discuss that the increased locomotion (horizontal activity) mainly characterizes the rat\'s behavioral response to novelty.

According to this research, the toxin showed degenerative effects on the pyramidal cells and produced a significant novelty behavior as well as change in the compartment entering.

Colchicine is an alkaloid, which is extracted from *Colchicum autumnale* L. This toxin binds to tubulin dimers, which results in the formation of a tubulin -- colchicine complex that acts primarily to prevent microtubule assembly.\[[@ref13]\] In animal cells, colchicine is usually considered as the lethal agent even at the lowest concentrations.\[[@ref14]\] This alkaloid impairs appearance of several learning paradigms by morris water maze, radial arm maze, aversive, and operant conditioning tasks.\[[@ref15][@ref16]\]

This work showed a damage effect of the colchicine on the small pyramidal cell population in the rat CA1 area. Supporting finding provides that the toxin colchicine irreversibly damages dendrites by disrupting their micro-tubular supporting network,\[[@ref16]\] a mechanism, which is expressed for the selective toxic effect of colchicine of dentate granule cells.\[[@ref17]\] Some other studies, furthermore, using similar doses of colchicine to ours in the present study have reported only the reversible effects.\[[@ref18]\] This alkaloid inhibits, the rapid axonal transport\[[@ref19]\] and produces long-lasting morphological changes in neurons and glia; it has been suggested that the axonal membrane as well as dendrites are the site for the action of colchicine.\[[@ref20][@ref21]\] Because these sites are rich in microtubules and contain specific receptors

As lesion studies specify, a critical role of CA1 in learning and memory processes\[[@ref22]\] we planned the learning tasks so effectively as needed to discuss on toxic effect of colchicine in the CA1. All rats were evaluated for sniffing, rearing, grooming, and compartment entering and the results provided some significant effects.

After place conditioning testing, the experimental animals, those suffering from the lesion made by colchicine (1-75 μg/rat) in the CA1 area, exhibited a different type of locomotor activity (compartment entering) in comparison to the control saline treated group (intra-CA1).

The axonal transport can be blocked by the microtubule-depolymerizing agent colchicine, so, this plant alkaloid can impair the functional properties of nerve cells. Individual difference in sensation-seeking responses has been reported as for instance, when rats are exposed to a novel environment, some rats (high responders) exhibit high locomotor response, while others (low responders) show low rates of locomotor activity.\[[@ref23]\] The odor sampling by sniffing behavior during the paradigm has encountered the idea that sniffing plays a critical role in odor information processing by shaping spatial and temporal patterns of afferent input to the olfactory bulb and through the patterns of higher level neural activity as well.\[[@ref24]\] Furthermore, in a survey in the novelty task rats with the CA1 lesions, impairment in the place conditioning test has been recorded.\[[@ref10]\]

Further, hippocampal lesions are associated with impairments in spatial navigation acquisition of conditional discriminations.\[[@ref25]\] The rats suffering from CA1 lesion cannot separate training events across time because they unable to lessen interfering of actions and undergo deficits in spatial learning.

Thus, the effects reported in the present study may be the consequence of an impaired neuronal transmission in hippocampal pyramidal cells, a process, which consequently may be related to the observed data. Based on the finding of this work, the small pyramidal cells can be chosen as another target for the action of colchicine, while the investigators have suggested the granular cells as the main candidate for destruction by the alkaloid.
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